Sets forth certain restrictions and limitations, including that: (1) appropriated funds made available to U.S. agencies may not be obligated to seek the revocation or revision of any intellectual property or competition law or policy of a developing country (including any sub- Saharan African country) that regulates HIV/AIDS pharmaceuticals or medical technologies if such law or policy promotes access to such drugs and technologies by the country's population; and (2) the USTR may not initiate a proceeding in the World Trade Organization (WTO) challenging any law or policy of a developing country (including a sub-Saharan African country) that promotes access by HIV/AIDS pharmaceuticals or medical technologies by the population of the country.
Requires the President to direct the U.S. representative to the WTO to urge the WTO and member countries to exempt developing countries (including sub-Saharan African countries) from the application of any provision of the Agreement on Trade-Related Aspects of Intellectual Property Rights or any other international agreement relating to intellectual property rights that would prohibit or restrict such countries from establishing or implementing any law or policy that promotes access to HIV/AIDS pharmaceuticals or medical technologies to their population.